Inflammation plays a pivotal role in the body’s defence against pathogens. It is part of a cascade of events that are crucial for maintaining organ and systemic homeostasis. While acute inflammatory responses are essential for combating infections, chronic inflammation is increasingly linked to the onset of various clinical conditions, including diabetes, atherosclerosis, cardiometabolic diseases, rheumatoid arthritis, and obesity.
Traditionally, C-Reactive Protein (CRP) has been the gold standard for assessing inflammation. However, recent studies highlight the importance of glycoproteins and lipoproteins in both acute and chronic inflammation. Notably, inflammation can alter the composition and influence the pro- or anti-inflammatory behaviour of HDL particles.
In this webinar, we will explore how Nuclear Magnetic Resonance (NMR*) technology provides robust, fine-grained measurements of glycoproteins and lipoproteins, offering a comprehensive inflammatory profile within minutes. Further, we will present how those models were translated to benchtop NMR spectrometers potentially revolutionizing the landscape of NMR lipoprotein measurements.
Join us for this insightful webinar and discover how our translational achievements in NMR technology are poised to revolutionize clinical research settings.
September 25, 2024 | 03:00 PM CEST
* Bruker NMR Instruments are for Research Use Only. Not for Use in Clinical Diagnostic Procedures
Julien Wist
Professor of Computational Spectroscopy | Deputy Director of the Center for Computational & Systems Medicine